This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

III. Methylphenidate Effects on Ultimate Height

Rachel Gittelman Klein, PhD; Salvatore Mannuzza, PhD

Arch Gen Psychiatry. 1988;45(12):1131-1134.

Abstract
• The height of young adults who were treated with methylphenidate hydrochloride in childhood because of hyperactivity (average daily dose, 45 mg; duration of treatment, six months to five years) was studied. There was no significant difference in height between the treated patients (n =61) and controls (n =99); both groups were at the national US norm in stature. The findings indicated that methylphenidate therapy does not compromise final height, even when it has an adverse impact on children's growth rate during the active treatment phase. A compensatory growth rate, or growth rebound, appears to occur following discontinuation of stimulant therapy.

Author Affiliations
From the New York State Psychiatric Institute and the Hillside Division, Long Island Jewish Medical Center, Glen Oaks, NY; and the Department of Psychiatry, Columbia University, New York.

Footnotes
Accepted for publication Feb 26, 1988.

Reprint requests to New York State Psychiatric Institute, Box 80, 722 W 168th St, New York, NY 10032 (Dr Klein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Focus 2008;6:401-426.
ABSTRACT | FULL TEXT  

Stimulants and Growth: Is It a Problem?
Schonwald
AAP Grand Rounds 2006;16:65-66.
FULL TEXT  

Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder
Gibson et al.
The Annals of Pharmacotherapy 2006;40:1134-1142.
ABSTRACT | FULL TEXT  

Growth on stimulant medication; clarifying the confusion: a review
Poulton
Arch. Dis. Child. 2005;90:801-806.
ABSTRACT | FULL TEXT  

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life
Harpin
Arch. Dis. Child. 2005;90:i2-i7.
ABSTRACT | FULL TEXT  

Growth Deficits and Attention-Deficit/Hyperactivity Disorder Revisited: Impact of Gender, Development, and Treatment
Biederman et al.
Pediatrics 2003;111:1010-1016.
ABSTRACT | FULL TEXT  

ADHD, Growth Deficits, and Relationships to Psychostimulant Use
Joshi and Adam
Pediatr. Rev. 2002;23:67-68.
FULL TEXT  

Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder
Vitiello
CMAJ 2001;165:1505-1506.
FULL TEXT  

Treatment of Attention-Deficit-Hyperactivity Disorder
Elia et al.
NEJM 1999;340:780-788.
FULL TEXT  

Growth Deficits in Children With Attention Deficit Hyperactivity Disorder
Spencer et al.
Pediatrics 1998;102:501-506.
ABSTRACT | FULL TEXT  

Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman et al.
JAMA 1998;279:1100-1107.
ABSTRACT | FULL TEXT  

Long-term Stimulant Treatment of Children With Attention-Deficit Hyperactivity Disorder Symptoms: A Randomized, Double-blind, Placebo-Controlled Trial
Gillberg et al.
Arch Gen Psychiatry 1997;54:857-864.
ABSTRACT  

The management of hyperactive children
DTB 1995;33:57-60.
ABSTRACT | FULL TEXT  

Therapy for Attention-Deficit Hyperactivity Disorder
Vinson
Arch Fam Med 1994;3:445-451.
ABSTRACT  

Clinical Management of Attention Deficit Hyperactivity Disorder
Voeller
J Child Neurol 1991;6:S51-S67.
ABSTRACT  

Methylphenidate and Growth in Hyperactive Children: A Controlled Withdrawal Study
Klein et al.
Arch Gen Psychiatry 1988;45:1127-1130.
ABSTRACT